Nasopharyngeal carcinomas may be divided into two broad anatomo-clinical groups-undifferentiated nasopharyngeal carcinoma and squamous cell carcinoma-on the basis of morphological criteria and anti-Epstein-Barr virus serology. ' 
Material and methods
Formalin fixed, paraffin embedded neoplastic tissue from 16 patients with carcinoma of the nasopharynx and from patients with squamous cell carcinoma of the oral cavity (two cases), larynx (two cases), and skin (four cases) were examined. Tissue slices were treated with 0-3% hydrogen peroxide in methanol for 20 min to block endogenous peroxidase activity and then processed for the immunoperoxidase reaction with the peroxidase-antiperoxidase method." Rabbit antiserum to S-100 either obtained commercially (Dakopatts a/s, Glostrup, Denmark) or produced by us as previously reported'2 was used at dilutions varying from 1/500 to 1/1000. The specificity of the immunostaining was confirmed by replacing the primary antiserum with non-immune rabbit serum or preabsorption of anti-S-100 antiserum with purified antigen. Slices were also reacted with rabbit anti-human muramidase (1/500) or antikeratin (1/400) antibodies (Dakopatts a/s, Glostrup, Denmark). were irregular in shape, often with dendritic features, and scattered throughout the neoplastic epithelial component (Figs. 1 and 2) . In some cases the S-100-labelled cells were evenly distributed among the neoplastic epithelial cells while in other cases they were unevenly dispersed. When the anaplastic tumour cells formed well defined masses in the lymphatic stroma no preferential location of the labelled cells at the periphery or in the central area of the nest was seen. Moreover, in some cases S-100 labelled cells with dendritic morphology were present in the accompanying lymphoid infiltrate, although they were less abundant than in the neo- 'not react with the antimuramidase antiserum (Fig.  4) . dendritic shaped S-100 containing labelled cells were seen in squamou of the oral cavity or larynx (Fig. 3 
